These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 9763203)

  • 1. Electrophysiological effects of felbamate.
    Corradetti R; Pugliese AM
    Life Sci; 1998; 63(13):1075-88. PubMed ID: 9763203
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Felbamate pharmacology and use in epilepsy.
    Burdette DE; Sackellares JC
    Clin Neuropharmacol; 1994 Oct; 17(5):389-402. PubMed ID: 9316688
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Felbamate overdose: a case report and discussion of a new antiepileptic drug.
    Nagel TR; Schunk JE
    Pediatr Emerg Care; 1995 Dec; 11(6):369-71. PubMed ID: 8751173
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Felbamate, a novel antiepileptic drug, reverses N-methyl-D-aspartate/glycine-stimulated increases in intracellular Ca2+ concentration.
    Taylor LA; McQuade RD; Tice MA
    Eur J Pharmacol; 1995 Apr; 289(2):229-33. PubMed ID: 7621896
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Felbamate: perspectives for new antiepileptic treatment].
    Pérez-Miranda J; Aguirre J; Parrilla JL; Pérez Miranda M
    Rev Neurol; 1995; 23(124):1220-5. PubMed ID: 8556622
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Felbamate. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in epilepsy.
    Palmer KJ; McTavish D
    Drugs; 1993 Jun; 45(6):1041-1065. PubMed ID: 7691493
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Selective antagonism of the anticonvulsant effects of felbamate by glycine.
    Coffin V; Cohen-Williams M; Barnett A
    Eur J Pharmacol; 1994 Apr; 256(2):R9-10. PubMed ID: 8050461
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Felbamate: a new antiepileptic drug.
    Wagner ML
    Am J Hosp Pharm; 1994 Jul; 51(13):1657-66. PubMed ID: 7942890
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Subtype-selective antagonism of N-methyl-D-aspartate receptors by felbamate: insights into the mechanism of action.
    Kleckner NW; Glazewski JC; Chen CC; Moscrip TD
    J Pharmacol Exp Ther; 1999 May; 289(2):886-94. PubMed ID: 10215667
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of felbamate in childhood epileptic encephalopathy (Lennox-Gastaut syndrome).
    Felbamate Study Group in Lennox-Gastaut Syndrome
    N Engl J Med; 1993 Jan; 328(1):29-33. PubMed ID: 8347179
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interaction of felbamate and diazepam against maximal electroshock seizures and chemoconvulsants in mice.
    Gordon R; Gels M; Diamantis W; Sofia RD
    Pharmacol Biochem Behav; 1991 Sep; 40(1):109-13. PubMed ID: 1664105
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Weight loss in patients taking felbamate.
    Bergen DC; Ristanovic RK; Waicosky K; Kanner A; Hoeppner TJ
    Clin Neuropharmacol; 1995 Feb; 18(1):23-7. PubMed ID: 8665531
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy of felbamate in the treatment of intractable pediatric epilepsy.
    Zupanc ML; Roell Werner R; Schwabe MS; O'Connor SE; Marcuccilli CJ; Hecox KE; Chico MS; Eggener KA
    Pediatr Neurol; 2010 Jun; 42(6):396-403. PubMed ID: 20472190
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influence of some convulsant agents on the protective activity of a novel antiepileptic drug, felbamate, against maximal electroshock in mice.
    Swiader M; Gasior M; Wielosz M; Czuczwar SJ
    Pol J Pharmacol; 2003; 55(4):649-53. PubMed ID: 14581726
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Felbamate therapy in the Lennox-Gastaut syndrome.
    Snodgrass SR
    N Engl J Med; 1993 Jun; 328(22):1641. PubMed ID: 8487814
    [No Abstract]   [Full Text] [Related]  

  • 16. Effect of anticonvulsant felbamate on GABAA receptor system.
    Ticku MK; Kamatchi GL; Sofia RD
    Epilepsia; 1991; 32(3):389-91. PubMed ID: 1646101
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mechanism of action of the anticonvulsant felbamate: opposing effects on N-methyl-D-aspartate and gamma-aminobutyric acidA receptors.
    Rho JM; Donevan SD; Rogawski MA
    Ann Neurol; 1994 Feb; 35(2):229-34. PubMed ID: 8109904
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Changes of the EEG paroxysmal pattern during felbamate therapy in Lennox-Gastaut syndrome: a case report.
    Marciani MG; Spanedda F; Placidi F; Bassetti MA; Romigi A; Mattia D
    Int J Neurosci; 1998 Sep; 95(3-4):247-53. PubMed ID: 9777442
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Felbamate and meprobamate: a comparison of their anticonvulsant properties.
    Frey HH; Bartels I
    Epilepsy Res; 1997 Jun; 27(3):151-64. PubMed ID: 9237049
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evidence for anticonvulsant and neuroprotectant action of felbamate mediated by strychnine-insensitive glycine receptors.
    McCabe RT; Wasterlain CG; Kucharczyk N; Sofia RD; Vogel JR
    J Pharmacol Exp Ther; 1993 Mar; 264(3):1248-52. PubMed ID: 8383742
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.